Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × B-Cell Malignancies × urelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Multiple Myeloma 1 Melanoma 1 Lymphoma, B-Cell 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 B-Cell Malignancies 1 Advanced Solid Malignancies 1

Interventions

urelumab 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01775631 2017-03-31

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

Bristol-Myers Squibb

Phase 1 Completed

B-Cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡